Egg-Based Flu Vaccines Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Egg-Based Flu Vaccines market size was valued at USD 7330.2 million in 2022 and is forecast to a readjusted size of USD 10170 million by 2029 with a CAGR of 4.8% during review period.

The most common way that flu vaccines are made is using an egg-based manufacturing process. that has been used for more than 70 years. Egg-based vaccine manufacturing is used to make both inactivated (killed) vaccine (usually called the “flu shot”) and live attenuated (weakened virus) vaccine (usually called the “nasal spray flu vaccine”).

A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.

Report includes an overview of the development of the Egg-Based Flu Vaccines industry chain, the market status of 6 Months to 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), > 3 Years (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Egg-Based Flu Vaccines.

Regionally, the report analyzes the Egg-Based Flu Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Egg-Based Flu Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Egg-Based Flu Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Egg-Based Flu Vaccines industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).

Industry Analysis: Report analyze the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Egg-Based Flu Vaccines market.

Regional Analysis: The report involves examining the Egg-Based Flu Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behavior to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Egg-Based Flu Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Egg-Based Flu Vaccines:

Company Analysis: Report covers individual Egg-Based Flu Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behavior, preferences, and attitudes towards Egg-Based Flu Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (6 Months to 3 Years, > 3 Years).

Technology Analysis: Report covers specific technologies relevant to Egg-Based Flu Vaccines. It assesses the current state, advancements, and potential future developments in Egg-Based Flu Vaccines areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Egg-Based Flu Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

   Sanofi
   CSL
   GSK
   Viatris
   AstraZeneca
   Hualan Bio
   Changchun Institute of Biological
   Sinovac
   BCHT
   Jiangsu GDK
   KM Biologics

   Trivalent Influenza Vaccine
   Quadrivalent Influenza Vaccine

   6 Months to 3 Years
   > 3 Years

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Egg-Based Flu Vaccines Market in 2025?

The egg-based flu vaccine market benefits from well-established production processes, cost-effectiveness, and a reliable track record of safety and efficacy. It has been the gold standard for flu vaccines for decades and is widely trusted by healthcare professionals.

What are the weaknesses of the Egg-Based Flu Vaccines Market in 2025?

The main weaknesses are the reliance on egg supply, which can cause production delays during avian diseases, and the limitations in production speed compared to newer technologies like cell-based or mRNA vaccines. Additionally, egg-based vaccines may not be as effective against some strains of the flu.

What opportunities are available in the Egg-Based Flu Vaccines Market in 2025?

With the rising global demand for flu vaccines, especially in developing nations, there’s an opportunity for expansion. Technological advancements could also lead to improvements in vaccine efficiency, reducing production time and improving strain coverage. Partnerships with global health organizations can drive growth in emerging markets.

What threats face the Egg-Based Flu Vaccines Market in 2025?

The increasing adoption of alternative vaccine technologies, such as cell-based and mRNA vaccines, presents a significant threat. Additionally, the impact of climate change, which could affect egg supply, and the ongoing global health crises, could disrupt production and distribution.

What are the political factors influencing the Egg-Based Flu Vaccines Market in 2025?

Government regulations and policies surrounding vaccine production, distribution, and approval play a critical role. Political stability and support for immunization programs, along with government funding, can impact the market's growth. International trade policies and export regulations also affect global vaccine availability.

How do economic factors impact the Egg-Based Flu Vaccines Market in 2025?

Economic conditions, including healthcare funding, affordability, and economic stability, influence the demand for vaccines. In lower-income regions, cost-effective production remains crucial. Economic downturns may reduce budgets for public health programs, potentially limiting vaccine access and distribution.

What social factors affect the Egg-Based Flu Vaccines Market in 2025?

Public perception of vaccines and trust in established flu vaccination methods affect market acceptance. Cultural beliefs and varying attitudes toward vaccination influence demand in different regions. Additionally, the growing awareness of flu prevention and vaccination campaigns can drive higher vaccine uptake.

What technological factors impact the Egg-Based Flu Vaccines Market in 2025?

Technological advancements in vaccine production, such as improvements in egg-based manufacturing processes, could lead to better efficiency. The rise of alternative vaccine technologies, like mRNA and cell-based vaccines, may create competition and challenge the dominance of egg-based methods.

What environmental factors affect the Egg-Based Flu Vaccines Market in 2025?

The impact of climate change on egg production due to disruptions in poultry farming is a key environmental concern. Additionally, sustainable practices in vaccine production and disposal are increasingly important, as the demand for greener, environmentally-friendly manufacturing processes grows.

What legal factors influence the Egg-Based Flu Vaccines Market in 2025?

Strict regulatory standards for vaccine approval, safety, and distribution are critical to maintaining consumer trust and market viability. Intellectual property laws also play a role in protecting vaccine technologies. Legal challenges around patents and global licensing agreements may influence market dynamics.

Who are the suppliers in the Egg-Based Flu Vaccines Market in 2025?

The suppliers include poultry farms providing eggs, vaccine manufacturers with production facilities, and suppliers of raw materials such as adjuvants, preservatives, and packaging materials. Additionally, companies involved in research and development for new flu strains contribute as key suppliers.

What inputs are essential for the Egg-Based Flu Vaccines Market in 2025?

Essential inputs include high-quality eggs, specialized vaccine production equipment, skilled labor for manufacturing, research data for flu strain identification, and raw materials for formulating the vaccines. Regulatory approvals and certifications are also necessary inputs to ensure vaccine safety and efficacy.

What processes are involved in the Egg-Based Flu Vaccines Market in 2025?

The key processes involve egg incubation, virus cultivation within the eggs, viral inactivation or attenuation, vaccine formulation, quality control, and packaging. Distribution logistics and ensuring compliance with healthcare regulations also play critical roles in the process flow.

Who are the customers in the Egg-Based Flu Vaccines Market in 2025?

Customers include government health agencies, healthcare providers, hospitals, pharmacies, and individuals seeking flu vaccinations. The market also caters to international organizations, NGOs, and private companies focusing on employee health and wellness programs.

What outputs are delivered in the Egg-Based Flu Vaccines Market in 2025?

The outputs include flu vaccines that are distributed to healthcare systems globally. These vaccines are used for public health immunization programs, private healthcare services, and emergency response efforts in the event of flu outbreaks or pandemics.

What is the threat of new entrants in the Egg-Based Flu Vaccines Market in 2025?

The threat of new entrants is moderate. While the egg-based vaccine market has high entry barriers due to the capital-intensive nature of production, regulatory hurdles, and established industry players, new technologies and partnerships may allow smaller or emerging companies to enter.

How intense is the rivalry among existing competitors in the Egg-Based Flu Vaccines Market in 2025?

Rivalry among existing competitors is high. Major pharmaceutical companies dominate the market, making it competitive. The need for continuous innovation, cost reduction, and efficient production methods intensifies competition, especially as newer vaccine technologies emerge.

What is the bargaining power of suppliers in the Egg-Based Flu Vaccines Market in 2025?

The bargaining power of suppliers is moderate. Egg production and raw material suppliers hold some power, particularly during disruptions in poultry farming or shortages. However, vaccine manufacturers often have multiple sources for these inputs, which reduces suppliers' leverage.

What is the bargaining power of buyers in the Egg-Based Flu Vaccines Market in 2025?

The bargaining power of buyers is moderate to high. While governments and large healthcare organizations can negotiate better prices due to bulk purchasing, individual consumers typically have limited bargaining power, especially in public health programs where vaccines are often subsidized.

What is the threat of substitute products in the Egg-Based Flu Vaccines Market in 2025?

The threat of substitutes is increasing. Alternatives like cell-based and mRNA vaccines are gaining traction and offer faster production times and potentially better effectiveness against a wider range of flu strains, making them a growing threat to traditional egg-based vaccines.

What are the key inputs for the Egg-Based Flu Vaccines Market in 2025?

The key inputs include high-quality eggs, which are used to cultivate the flu virus, as well as adjuvants, preservatives, and other raw materials required for formulating the vaccine. Specialized equipment and skilled labor for vaccine production also play a significant role.

How dependent is the Egg-Based Flu Vaccines Market on suppliers?

The market is highly dependent on suppliers, particularly poultry farms for egg production. Any disruption in the egg supply, such as due to disease outbreaks or climatic conditions, can significantly impact vaccine production timelines and costs. Additionally, the availability of raw materials and equipment is critical to maintaining smooth production processes.

What are the potential risks in the upstream supply chain for Egg-Based Flu Vaccines in 2025?

The main risks in the upstream supply chain include disruptions in egg supply, which can be affected by avian diseases or environmental factors. Supply chain disruptions for raw materials or equipment, regulatory changes, and the increasing reliance on alternative vaccine production methods like cell-based technologies pose additional risks.

How does the upstream supply chain impact production costs in the Egg-Based Flu Vaccines Market?

Upstream supply chain factors, such as the cost of eggs and raw materials, significantly affect production costs. Any increase in the price of eggs or disruptions in the supply chain can lead to higher production expenses, impacting the overall cost of the vaccine. Additionally, fluctuations in labor and equipment costs further contribute to variability in production costs.

What role does innovation play in the upstream supply chain for Egg-Based Flu Vaccines in 2025?

Innovation in upstream processes, such as improving egg quality, enhancing virus cultivation methods, or developing more efficient manufacturing technologies, can help reduce costs and improve vaccine yields. Investment in sustainable and scalable production methods can also ensure stability in the supply chain while addressing growing global demand.

What are the key processes in the midstream stage of the Egg-Based Flu Vaccines Market in 2025?

Key processes in the midstream stage include the virus cultivation in eggs, inactivation or attenuation of the virus, vaccine formulation, and quality control testing. Packaging and labeling are also critical steps before the vaccines are ready for distribution to healthcare providers or public health agencies.

How does the midstream stage impact the overall production of Egg-Based Flu Vaccines?

The midstream stage directly impacts the efficacy, safety, and consistency of the final vaccine product. The success of virus cultivation, the quality of inactivation methods, and adherence to stringent quality control standards are essential for ensuring a safe and effective vaccine for the population.

What challenges exist in the midstream supply chain for Egg-Based Flu Vaccines in 2025?

Challenges include maintaining the consistent quality of eggs for virus cultivation and ensuring the reliability of production facilities. Variability in egg quality due to environmental or disease-related disruptions can affect the virus yield, leading to delays or reduced vaccine output. Additionally, the complexity of maintaining high standards in vaccine formulation and testing can slow production.

How does regulatory oversight affect the midstream processes in the Egg-Based Flu Vaccines Market?

Regulatory oversight is crucial in ensuring the safety and efficacy of vaccines. Strict guidelines and quality control requirements set by health authorities like the FDA or WHO impact every step in the midstream process. Compliance with these regulations can affect production timelines and costs but is necessary for market approval and public confidence.

What role does technological advancement play in the midstream process of Egg-Based Flu Vaccines?

Technological advancements in vaccine production, such as improved virus cultivation methods, faster testing protocols, and more efficient formulation techniques, can streamline the midstream process. Innovation in these areas can enhance production capacity, reduce costs, and ensure that vaccines are available in a timely manner, especially during peak flu seasons.

What are the key activities in the downstream stage of the Egg-Based Flu Vaccines Market in 2025?

Key activities in the downstream stage include the distribution and delivery of vaccines to healthcare providers, pharmacies, and government health programs. Post-production monitoring, public health campaigns, and ensuring timely vaccination schedules are also crucial components of the downstream process.

How does the downstream process impact the availability of Egg-Based Flu Vaccines?

The downstream process plays a significant role in ensuring that vaccines reach the end-users effectively. Efficient distribution channels and timely delivery to various healthcare providers directly impact vaccine accessibility, especially during peak flu seasons. Delays in distribution can lead to shortages and affect vaccination rates.

What challenges are faced in the downstream supply chain for Egg-Based Flu Vaccines in 2025?

Challenges include logistical issues such as maintaining the cold chain during transportation and ensuring vaccines are distributed to areas in need. Regulatory barriers and varying healthcare infrastructure across regions can also affect vaccine availability. Additionally, fluctuating demand and competition from newer vaccine technologies may complicate distribution efforts.

How does public awareness influence the downstream dynamics of the Egg-Based Flu Vaccines Market?

Public awareness campaigns are crucial in driving vaccine uptake. Effective communication about the importance of flu vaccinations and the availability of egg-based vaccines in local healthcare settings directly impacts demand. Lack of awareness or misinformation can lead to vaccine hesitancy, reducing the success of vaccination campaigns.

What role does pricing play in the downstream stage of the Egg-Based Flu Vaccines Market?

Pricing affects both accessibility and demand. Government-subsidized or low-cost vaccines can drive higher uptake in low-income regions, whereas higher prices can limit access, particularly in developing markets. Pricing strategies must balance affordability with the need to maintain profitability for vaccine manufacturers.

Chapter 1, to describe Egg-Based Flu Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Egg-Based Flu Vaccines, with price, sales, revenue and global market share of Egg-Based Flu Vaccines from 2018 to 2023.
Chapter 3, the Egg-Based Flu Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Egg-Based Flu Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Egg-Based Flu Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Egg-Based Flu Vaccines.
Chapter 14 and 15, to describe Egg-Based Flu Vaccines sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Egg-Based Flu Vaccines
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Egg-Based Flu Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Trivalent Influenza Vaccine
       1.3.3 Quadrivalent Influenza Vaccine
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Egg-Based Flu Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 6 Months to 3 Years
       1.4.3 > 3 Years
   1.5 Global Egg-Based Flu Vaccines Market Size & Forecast
       1.5.1 Global Egg-Based Flu Vaccines Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Egg-Based Flu Vaccines Sales Quantity (2018-2029)
       1.5.3 Global Egg-Based Flu Vaccines Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 Sanofi
       2.1.1 Sanofi Details
       2.1.2 Sanofi Major Business
       2.1.3 Sanofi Egg-Based Flu Vaccines Product and Services
       2.1.4 Sanofi Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Sanofi Recent Developments/Updates
   2.2 CSL
       2.2.1 CSL Details
       2.2.2 CSL Major Business
       2.2.3 CSL Egg-Based Flu Vaccines Product and Services
       2.2.4 CSL Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 CSL Recent Developments/Updates
   2.3 GSK
       2.3.1 GSK Details
       2.3.2 GSK Major Business
       2.3.3 GSK Egg-Based Flu Vaccines Product and Services
       2.3.4 GSK Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 GSK Recent Developments/Updates
   2.4 Viatris
       2.4.1 Viatris Details
       2.4.2 Viatris Major Business
       2.4.3 Viatris Egg-Based Flu Vaccines Product and Services
       2.4.4 Viatris Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Viatris Recent Developments/Updates
   2.5 AstraZeneca
       2.5.1 AstraZeneca Details
       2.5.2 AstraZeneca Major Business
       2.5.3 AstraZeneca Egg-Based Flu Vaccines Product and Services
       2.5.4 AstraZeneca Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 AstraZeneca Recent Developments/Updates
   2.6 Hualan Bio
       2.6.1 Hualan Bio Details
       2.6.2 Hualan Bio Major Business
       2.6.3 Hualan Bio Egg-Based Flu Vaccines Product and Services
       2.6.4 Hualan Bio Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Hualan Bio Recent Developments/Updates
   2.7 Changchun Institute of Biological
       2.7.1 Changchun Institute of Biological Details
       2.7.2 Changchun Institute of Biological Major Business
       2.7.3 Changchun Institute of Biological Egg-Based Flu Vaccines Product and Services
       2.7.4 Changchun Institute of Biological Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Changchun Institute of Biological Recent Developments/Updates
   2.8 Sinovac
       2.8.1 Sinovac Details
       2.8.2 Sinovac Major Business
       2.8.3 Sinovac Egg-Based Flu Vaccines Product and Services
       2.8.4 Sinovac Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Sinovac Recent Developments/Updates
   2.9 BCHT
       2.9.1 BCHT Details
       2.9.2 BCHT Major Business
       2.9.3 BCHT Egg-Based Flu Vaccines Product and Services
       2.9.4 BCHT Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 BCHT Recent Developments/Updates
   2.10 Jiangsu GDK
       2.10.1 Jiangsu GDK Details
       2.10.2 Jiangsu GDK Major Business
       2.10.3 Jiangsu GDK Egg-Based Flu Vaccines Product and Services
       2.10.4 Jiangsu GDK Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Jiangsu GDK Recent Developments/Updates
   2.11 KM Biologics
       2.11.1 KM Biologics Details
       2.11.2 KM Biologics Major Business
       2.11.3 KM Biologics Egg-Based Flu Vaccines Product and Services
       2.11.4 KM Biologics Egg-Based Flu Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 KM Biologics Recent Developments/Updates

3 Competitive Environment: Egg-Based Flu Vaccines by Manufacturer

   3.1 Global Egg-Based Flu Vaccines Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Egg-Based Flu Vaccines Revenue by Manufacturer (2018-2023)
   3.3 Global Egg-Based Flu Vaccines Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Egg-Based Flu Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Egg-Based Flu Vaccines Manufacturer Market Share in 2022
       3.4.2 Top 6 Egg-Based Flu Vaccines Manufacturer Market Share in 2022
   3.5 Egg-Based Flu Vaccines Market: Overall Company Footprint Analysis
       3.5.1 Egg-Based Flu Vaccines Market: Region Footprint
       3.5.2 Egg-Based Flu Vaccines Market: Company Product Type Footprint
       3.5.3 Egg-Based Flu Vaccines Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Egg-Based Flu Vaccines Market Size by Region
       4.1.1 Global Egg-Based Flu Vaccines Sales Quantity by Region (2018-2029)
       4.1.2 Global Egg-Based Flu Vaccines Consumption Value by Region (2018-2029)
       4.1.3 Global Egg-Based Flu Vaccines Average Price by Region (2018-2029)
   4.2 North America Egg-Based Flu Vaccines Consumption Value (2018-2029)
   4.3 Europe Egg-Based Flu Vaccines Consumption Value (2018-2029)
   4.4 Asia-Pacific Egg-Based Flu Vaccines Consumption Value (2018-2029)
   4.5 South America Egg-Based Flu Vaccines Consumption Value (2018-2029)
   4.6 Middle East and Africa Egg-Based Flu Vaccines Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
   5.2 Global Egg-Based Flu Vaccines Consumption Value by Type (2018-2029)
   5.3 Global Egg-Based Flu Vaccines Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
   6.2 Global Egg-Based Flu Vaccines Consumption Value by Application (2018-2029)
   6.3 Global Egg-Based Flu Vaccines Average Price by Application (2018-2029)

7 North America

   7.1 North America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
   7.2 North America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
   7.3 North America Egg-Based Flu Vaccines Market Size by Country
       7.3.1 North America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
       7.3.2 North America Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
   8.2 Europe Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
   8.3 Europe Egg-Based Flu Vaccines Market Size by Country
       8.3.1 Europe Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
       8.3.2 Europe Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Egg-Based Flu Vaccines Market Size by Region
       9.3.1 Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Egg-Based Flu Vaccines Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
   10.2 South America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
   10.3 South America Egg-Based Flu Vaccines Market Size by Country
       10.3.1 South America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
       10.3.2 South America Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Egg-Based Flu Vaccines Market Size by Country
       11.3.1 Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Egg-Based Flu Vaccines Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Egg-Based Flu Vaccines Market Drivers
   12.2 Egg-Based Flu Vaccines Market Restraints
   12.3 Egg-Based Flu Vaccines Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

   13.1 Raw Material of Egg-Based Flu Vaccines and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Egg-Based Flu Vaccines
   13.3 Egg-Based Flu Vaccines Production Process
   13.4 Egg-Based Flu Vaccines Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Egg-Based Flu Vaccines Typical Distributors
   14.3 Egg-Based Flu Vaccines Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Egg-Based Flu Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Egg-Based Flu Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
   Table 4. Sanofi Major Business
   Table 5. Sanofi Egg-Based Flu Vaccines Product and Services
   Table 6. Sanofi Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. Sanofi Recent Developments/Updates
   Table 8. CSL Basic Information, Manufacturing Base and Competitors
   Table 9. CSL Major Business
   Table 10. CSL Egg-Based Flu Vaccines Product and Services
   Table 11. CSL Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. CSL Recent Developments/Updates
   Table 13. GSK Basic Information, Manufacturing Base and Competitors
   Table 14. GSK Major Business
   Table 15. GSK Egg-Based Flu Vaccines Product and Services
   Table 16. GSK Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. GSK Recent Developments/Updates
   Table 18. Viatris Basic Information, Manufacturing Base and Competitors
   Table 19. Viatris Major Business
   Table 20. Viatris Egg-Based Flu Vaccines Product and Services
   Table 21. Viatris Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Viatris Recent Developments/Updates
   Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
   Table 24. AstraZeneca Major Business
   Table 25. AstraZeneca Egg-Based Flu Vaccines Product and Services
   Table 26. AstraZeneca Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. AstraZeneca Recent Developments/Updates
   Table 28. Hualan Bio Basic Information, Manufacturing Base and Competitors
   Table 29. Hualan Bio Major Business
   Table 30. Hualan Bio Egg-Based Flu Vaccines Product and Services
   Table 31. Hualan Bio Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Hualan Bio Recent Developments/Updates
   Table 33. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
   Table 34. Changchun Institute of Biological Major Business
   Table 35. Changchun Institute of Biological Egg-Based Flu Vaccines Product and Services
   Table 36. Changchun Institute of Biological Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. Changchun Institute of Biological Recent Developments/Updates
   Table 38. Sinovac Basic Information, Manufacturing Base and Competitors
   Table 39. Sinovac Major Business
   Table 40. Sinovac Egg-Based Flu Vaccines Product and Services
   Table 41. Sinovac Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Sinovac Recent Developments/Updates
   Table 43. BCHT Basic Information, Manufacturing Base and Competitors
   Table 44. BCHT Major Business
   Table 45. BCHT Egg-Based Flu Vaccines Product and Services
   Table 46. BCHT Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. BCHT Recent Developments/Updates
   Table 48. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
   Table 49. Jiangsu GDK Major Business
   Table 50. Jiangsu GDK Egg-Based Flu Vaccines Product and Services
   Table 51. Jiangsu GDK Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 52. Jiangsu GDK Recent Developments/Updates
   Table 53. KM Biologics Basic Information, Manufacturing Base and Competitors
   Table 54. KM Biologics Major Business
   Table 55. KM Biologics Egg-Based Flu Vaccines Product and Services
   Table 56. KM Biologics Egg-Based Flu Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 57. KM Biologics Recent Developments/Updates
   Table 58. Global Egg-Based Flu Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
   Table 59. Global Egg-Based Flu Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 60. Global Egg-Based Flu Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
   Table 61. Market Position of Manufacturers in Egg-Based Flu Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 62. Head Office and Egg-Based Flu Vaccines Production Site of Key Manufacturer
   Table 63. Egg-Based Flu Vaccines Market: Company Product Type Footprint
   Table 64. Egg-Based Flu Vaccines Market: Company Product Application Footprint
   Table 65. Egg-Based Flu Vaccines New Market Entrants and Barriers to Market Entry
   Table 66. Egg-Based Flu Vaccines Mergers, Acquisition, Agreements, and Collaborations
   Table 67. Global Egg-Based Flu Vaccines Sales Quantity by Region (2018-2023) & (K Units)
   Table 68. Global Egg-Based Flu Vaccines Sales Quantity by Region (2024-2029) & (K Units)
   Table 69. Global Egg-Based Flu Vaccines Consumption Value by Region (2018-2023) & (USD Million)
   Table 70. Global Egg-Based Flu Vaccines Consumption Value by Region (2024-2029) & (USD Million)
   Table 71. Global Egg-Based Flu Vaccines Average Price by Region (2018-2023) & (US$/Unit)
   Table 72. Global Egg-Based Flu Vaccines Average Price by Region (2024-2029) & (US$/Unit)
   Table 73. Global Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
   Table 74. Global Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
   Table 75. Global Egg-Based Flu Vaccines Consumption Value by Type (2018-2023) & (USD Million)
   Table 76. Global Egg-Based Flu Vaccines Consumption Value by Type (2024-2029) & (USD Million)
   Table 77. Global Egg-Based Flu Vaccines Average Price by Type (2018-2023) & (US$/Unit)
   Table 78. Global Egg-Based Flu Vaccines Average Price by Type (2024-2029) & (US$/Unit)
   Table 79. Global Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
   Table 80. Global Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
   Table 81. Global Egg-Based Flu Vaccines Consumption Value by Application (2018-2023) & (USD Million)
   Table 82. Global Egg-Based Flu Vaccines Consumption Value by Application (2024-2029) & (USD Million)
   Table 83. Global Egg-Based Flu Vaccines Average Price by Application (2018-2023) & (US$/Unit)
   Table 84. Global Egg-Based Flu Vaccines Average Price by Application (2024-2029) & (US$/Unit)
   Table 85. North America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
   Table 86. North America Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
   Table 87. North America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
   Table 88. North America Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
   Table 89. North America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2023) & (K Units)
   Table 90. North America Egg-Based Flu Vaccines Sales Quantity by Country (2024-2029) & (K Units)
   Table 91. North America Egg-Based Flu Vaccines Consumption Value by Country (2018-2023) & (USD Million)
   Table 92. North America Egg-Based Flu Vaccines Consumption Value by Country (2024-2029) & (USD Million)
   Table 93. Europe Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
   Table 94. Europe Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
   Table 95. Europe Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
   Table 96. Europe Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
   Table 97. Europe Egg-Based Flu Vaccines Sales Quantity by Country (2018-2023) & (K Units)
   Table 98. Europe Egg-Based Flu Vaccines Sales Quantity by Country (2024-2029) & (K Units)
   Table 99. Europe Egg-Based Flu Vaccines Consumption Value by Country (2018-2023) & (USD Million)
   Table 100. Europe Egg-Based Flu Vaccines Consumption Value by Country (2024-2029) & (USD Million)
   Table 101. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
   Table 102. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
   Table 103. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
   Table 104. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
   Table 105. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Region (2018-2023) & (K Units)
   Table 106. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity by Region (2024-2029) & (K Units)
   Table 107. Asia-Pacific Egg-Based Flu Vaccines Consumption Value by Region (2018-2023) & (USD Million)
   Table 108. Asia-Pacific Egg-Based Flu Vaccines Consumption Value by Region (2024-2029) & (USD Million)
   Table 109. South America Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
   Table 110. South America Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
   Table 111. South America Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
   Table 112. South America Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
   Table 113. South America Egg-Based Flu Vaccines Sales Quantity by Country (2018-2023) & (K Units)
   Table 114. South America Egg-Based Flu Vaccines Sales Quantity by Country (2024-2029) & (K Units)
   Table 115. South America Egg-Based Flu Vaccines Consumption Value by Country (2018-2023) & (USD Million)
   Table 116. South America Egg-Based Flu Vaccines Consumption Value by Country (2024-2029) & (USD Million)
   Table 117. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Type (2018-2023) & (K Units)
   Table 118. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Type (2024-2029) & (K Units)
   Table 119. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Application (2018-2023) & (K Units)
   Table 120. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Application (2024-2029) & (K Units)
   Table 121. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Region (2018-2023) & (K Units)
   Table 122. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity by Region (2024-2029) & (K Units)
   Table 123. Middle East & Africa Egg-Based Flu Vaccines Consumption Value by Region (2018-2023) & (USD Million)
   Table 124. Middle East & Africa Egg-Based Flu Vaccines Consumption Value by Region (2024-2029) & (USD Million)
   Table 125. Egg-Based Flu Vaccines Raw Material
   Table 126. Key Manufacturers of Egg-Based Flu Vaccines Raw Materials
   Table 127. Egg-Based Flu Vaccines Typical Distributors
   Table 128. Egg-Based Flu Vaccines Typical Customers

List of Figures

   Figure 1. Egg-Based Flu Vaccines Picture
   Figure 2. Global Egg-Based Flu Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Egg-Based Flu Vaccines Consumption Value Market Share by Type in 2022
   Figure 4. Trivalent Influenza Vaccine Examples
   Figure 5. Quadrivalent Influenza Vaccine Examples
   Figure 6. Global Egg-Based Flu Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 7. Global Egg-Based Flu Vaccines Consumption Value Market Share by Application in 2022
   Figure 8. 6 Months to 3 Years Examples
   Figure 9. > 3 Years Examples
   Figure 10. Global Egg-Based Flu Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 11. Global Egg-Based Flu Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 12. Global Egg-Based Flu Vaccines Sales Quantity (2018-2029) & (K Units)
   Figure 13. Global Egg-Based Flu Vaccines Average Price (2018-2029) & (US$/Unit)
   Figure 14. Global Egg-Based Flu Vaccines Sales Quantity Market Share by Manufacturer in 2022
   Figure 15. Global Egg-Based Flu Vaccines Consumption Value Market Share by Manufacturer in 2022
   Figure 16. Producer Shipments of Egg-Based Flu Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 17. Top 3 Egg-Based Flu Vaccines Manufacturer (Consumption Value) Market Share in 2022
   Figure 18. Top 6 Egg-Based Flu Vaccines Manufacturer (Consumption Value) Market Share in 2022
   Figure 19. Global Egg-Based Flu Vaccines Sales Quantity Market Share by Region (2018-2029)
   Figure 20. Global Egg-Based Flu Vaccines Consumption Value Market Share by Region (2018-2029)
   Figure 21. North America Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 22. Europe Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 23. Asia-Pacific Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 24. South America Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 25. Middle East & Africa Egg-Based Flu Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 26. Global Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 27. Global Egg-Based Flu Vaccines Consumption Value Market Share by Type (2018-2029)
   Figure 28. Global Egg-Based Flu Vaccines Average Price by Type (2018-2029) & (US$/Unit)
   Figure 29. Global Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 30. Global Egg-Based Flu Vaccines Consumption Value Market Share by Application (2018-2029)
   Figure 31. Global Egg-Based Flu Vaccines Average Price by Application (2018-2029) & (US$/Unit)
   Figure 32. North America Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 33. North America Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 34. North America Egg-Based Flu Vaccines Sales Quantity Market Share by Country (2018-2029)
   Figure 35. North America Egg-Based Flu Vaccines Consumption Value Market Share by Country (2018-2029)
   Figure 36. United States Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 37. Canada Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 38. Mexico Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 39. Europe Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 40. Europe Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 41. Europe Egg-Based Flu Vaccines Sales Quantity Market Share by Country (2018-2029)
   Figure 42. Europe Egg-Based Flu Vaccines Consumption Value Market Share by Country (2018-2029)
   Figure 43. Germany Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 44. France Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 45. United Kingdom Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 46. Russia Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. Italy Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 49. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 50. Asia-Pacific Egg-Based Flu Vaccines Sales Quantity Market Share by Region (2018-2029)
   Figure 51. Asia-Pacific Egg-Based Flu Vaccines Consumption Value Market Share by Region (2018-2029)
   Figure 52. China Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 53. Japan Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 54. Korea Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 55. India Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Southeast Asia Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Australia Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. South America Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 59. South America Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 60. South America Egg-Based Flu Vaccines Sales Quantity Market Share by Country (2018-2029)
   Figure 61. South America Egg-Based Flu Vaccines Consumption Value Market Share by Country (2018-2029)
   Figure 62. Brazil Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 63. Argentina Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 64. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 65. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 66. Middle East & Africa Egg-Based Flu Vaccines Sales Quantity Market Share by Region (2018-2029)
   Figure 67. Middle East & Africa Egg-Based Flu Vaccines Consumption Value Market Share by Region (2018-2029)
   Figure 68. Turkey Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 69. Egypt Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 70. Saudi Arabia Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 71. South Africa Egg-Based Flu Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Egg-Based Flu Vaccines Market Drivers
   Figure 73. Egg-Based Flu Vaccines Market Restraints
   Figure 74. Egg-Based Flu Vaccines Market Trends
   Figure 75. Porters Five Forces Analysis
   Figure 76. Manufacturing Cost Structure Analysis of Egg-Based Flu Vaccines in 2022
   Figure 77. Manufacturing Process Analysis of Egg-Based Flu Vaccines
   Figure 78. Egg-Based Flu Vaccines Industrial Chain
   Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 80. Direct Channel Pros & Cons
   Figure 81. Indirect Channel Pros & Cons
   Figure 82. Methodology
   Figure 83. Research Process and Data Source